The combination of RF and ANA is no longer included in the criteria, and anti-SSB positivity has been removed from the criteria since positive anti-SSB in the absence of anti-SSA has no significant association with SS phenotypic features [8, 9]. This evidence concerns the gene BTG3 and synovial sarcoma.